I assigned a Hold rating to ImmunityBio, Inc. (IBRX) stock back in September last year in a note for Seeking Alpha, and prior to that, a Hold rating in April 2025, and a Buy rating in December 2024.
Are you guys itching to get your hands on the latest Apple iPhone 17? Or maybe you’ve had your eyes on the Samsung Galaxy S25 series instead? There’s always a lot of hype in the air whenever a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results